For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Report Scope:
While this report will discuss applicable complementary technologies, it will not go into the market specifics of these complementary technologies. Of particular note are the majority of reagents used for PCR, as there is significant overlap between the reagents used for digital PCR and those used for real-time PCR. This report will focus on the equipment used for digital PCR, reagents specific to the technology, and any particular applications. There will be significant discussion of the end users, including academia, industry, clinical laboratories, and other users.
Report Includes:
- 14 data tables and 7 additional tables
- An overview of the global market for digital polymerase chain reaction (PCR) technology
- Analyses of global market trends, with data from 2016, and estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
- Discussion of key manufacturers, suppliers, users, and a variety of factors influencing demand
- Relevant Patent analyses
- Comprehensive company profiles of major players in the market, including Abbott Laboratories, Celula Inc., Fluidigm Corp., IntegenX Inc. and Stilla Technologies
Summary
The digital PCR market will grow from REDACTED in 2017 to REDACTED in 2022, with a compound annual growth rate (CAGR) of REDACTED. The digital PCR equipment market will grow from REDACTED in revenue in 2017 to REDACTED in 2022, with a CAGR of REDACTED. The digital PCR consumables market will grow from REDACTED in 2017 to REDACTED in 2022, with a CAGR of REDACTED. As the technology matures, growth rates will slow, but the current explosive growth in digital PCR is due to a number of factors.
Novel uses for digital PCR are driving increased adoption of the technology, particularly in sectors such as agriculture, food, and environmental science. Integration of digital PCR in next-generation sequencing (NGS) workflows as a means of detecting the quality of samples has also encouraged the spread of digital PCR. While equipment purchasing growth has slowed somewhat, particularly in earlyadopting sectors such as pharmaceutical R&D and infectious disease, use of digital PCR equipment will grow as new uses for the technology emerge.
Digital PCR growth is particularly driven by development in the clinical diagnostic space. As there is more experience with the technology in this space, digital PCR has found a niche here among other PCR technologies. Growth in this sector has also been driven by the development of new assay and samplepreparation technologies to complement digital PCR. This growth and refinement of the technology will drive the use of digital PCR consumables in all sectors of the life sciences and will support industrial growth for at least the next five years.
Reasons for Doing This Study
Digital PCR is a novel application of the now 30-year-old PCR technology. The concept involves partitioning a sample of DNA into small, microscopic droplets so that a given sample has either zero or one copy of target DNA, much in the way a microchip has switches that gives signals of 0 or 1 within a microchip. Once the sample is partitioned, a PCR reaction takes place in each droplet, which is then detected by technologies similar to those used in quantitative PCR today. These results are interpreted with the use of Poisson statistics to determine the exact copy number of target DNA within a sample. This methodology has the ability to quantify small copy numbers of DNA within a sample, and it can have a wide variety of applications complementary to existing PCR technology, as well as allowing new uses of PCR that would not be feasible with other technologiesparticularly as a complement to nextgeneration sequencing. There are three different variations of digital PCR being marketed, and they all have their strengths and weaknesses.